Moreover, as high viral loads have been detected in the saliva of COVID-19 patients (61, 62), oral delivery is being explored for a clinical-grade nonglycosylated full-length ACE2 fused with cholera toxin B (CTB-ACE2), expressed in plant cells and delivered through a chewing gum (41, 63–66). This evidence concerns the gene ACE2 and COVID-19.